Fast Money

Monday - Friday, 5:00 - 6:00 PM ET

Fast Money

Your first trade for Thursday, November 29

Final Trades: CVS, GM & more
VIDEO0:5100:51
Final Trades: CVS, GM & more

The "Fast Money" traders shared their first moves for the market open.

Pete Najarian was a buyer of CVS.

Tim Seymour was a buyer of General Motors.

Steve Grasso was a buyer of the utilities ETF.

Guy Adami was a buyer of Valero

Trader disclosure: On November 28, 2018 the following stocks and commodities mentioned or intended to be mentioned on CNBC's "Fast Money" were owned by the "Fast Money" traders: Pete Najarian is long calls ACWC, ARNC, C, CAKE, CL, DVN, ECA, EEM, EWW, EWZ, KNX, MDR, NVS, OIM, PG, PYPL, WWE, XLF, XLI. Pete is long stock AAPL, ABBV, AMP, BAC, C, CAT, CVS, CVX, DIS, DVA, EBAY, FB, FUL, GILD, GM, HLT, IBM, INTC, JPM,  KMI, KO, LOW, LULU, LVS, MRK, MSFT, MU, NFLX, NSC, PEP, PFE, PII, RF, STZ, TGT, UPS, UPWK, USB, XOM. Pete is long GE, XOP puts. Tim Seymour is long ACBFF, AMZA, ACB, APC, APH, BABA, BAC, BIDU, BX, C, CCJ, CGC, CLF, CMG, CNTTF, CRON, CSCO, CWEB, CX, DAL, DIS, DPZ, DVYE, EA, EEM, EUFN, EWM, FB, FXI, GE, GILD, GM, GOOGL, GTII, GWPH, HAL, HK.APH, HYYDF, INTC, ITHUF, JD, KHRNF, KSHB, LEAF, MAT, MCD, MJNE, MO, MOS, MPEL, MPX, MRMD, NKE, OGI, ORGMF, OTC, PAK, PHM, PYPL, RH, RL, SBUX, SQ, STZ, T, TER, TIF, TGOD, TRSSF, TRST, TWTR, UA, UAL, VALE, VIAB, VOD, X, XLE, XRT, YNDX, 700.   Tim is on the advisory board of Tikun Olam, TGOD, CCTV, and MJ Holdings. Tim is short IWM, RACE, SPY. Tim's firm is long CGC, HEXO, TLRY, CRON, APH. Steve Grasso is long stock AAPL, BABA, BHC, CAR, CGC, EVGN, GE, JCP, LEN, MJNA, OSTK, PFE, RAD, SNAP, SQ, T, TWTR. Grasso owns Callable Trigger contingent yield note linked to SPX, RTY, and MXEA. Grasso's kids own EFA, EFG, EWJ, IJR, SPY, TUR. Grasso's firm is long stock APC, BGCP, COTY, CUBA, DVN, EOG, F, GE, GLD, GSK, HPQ, IAU, IBM, ICE, KHC, LEN, MAT, MSFT, MJNA, NE, QCOM, RIG, SLB, SNAP, SNGX, T, URI, WDR, WHR, ZNGA. Guy Adami is long CELG, EXAS, GDX, INTC. Guy Adami's wife, Linda Snow, works at Merck.